Spinal muscular atrophy (SMA) is an autosomal recessive disease in humans that is characterized by degeneration of the ␣-motor neurons of the spinal cord anterior horn. Infants born with SMA exhibit progressive muscle atrophy and paralysis that leads to respiratory failure and early death. Severe forms of SMA are caused by mutation of the survival motor neurons 1 (SMN1) gene (11, 24, 28, 51) .
Two copies of the human SMN gene (SMN1 and SMN2) that are located in an inverted repeat on chromosome 5q13 have been identified. These two genes are very similar, but transcripts from the SMN2 gene undergo alternative splicing due to a translationally silent nucleotide difference (C 3 T, codon 280) in exon 7 (31, 36) . In severe forms of SMA, the SMN1 gene is deleted and the SMN2 gene predominantly expresses a truncated SMN protein that lacks sequences derived from exon 7. The expression of low levels of full-length SMN protein causes motor neuron degeneration and SMA.
SMN has been implicated in the growth, development, and survival of spinal cord motor neurons (34, 42, 44) . Biochemical analysis demonstrates that SMN plays an essential role in the assembly and maturation of spliceosomal small nuclear ribonucleoproteins (snRNPs) (35, 43, 53) . After transcription, the Sm class of snRNAs (U1, U2, U4, and U5) are exported to the cytoplasm, where they are assembled with seven Sm proteins (SmB/B', SmD1 to SmD3, SmE, SmF, and SmG) to form Sm-core. The SMN protein complex is required for the specific assembly of Sm-core complexes on U snRNAs. This is mediated by SMN interactions with the U snRNA (52) and with the Arg/Gly-rich COOH tails of SmB, SmD1, and SmD3 (9) . Highaffinity interactions with SMN require that these Sm proteins be modified to contain symmetrical dimethyl-arginine (4, 10) .
SMN plays a second role in the maturation of snRNPs following the assembly of snRNAs with Sm proteins. The Sm-core undergoes hypermethylation to form the 2Ј,2Ј,7Ј-trimethylguanosine (TMG) 5Ј-cap that is required for the recruitment of import receptors necessary for the translocation of snRNPs into the nucleus (50) . Trimethylguanosine synthase 1 (TSG1), the enzyme that is responsible for the formation of the TMG 5Ј-cap, interacts with SMN (37) . The hypermethylated 5Ј-cap of U snRNA recruits snurportin 1 to the snRNP complex (21) and snurportin 1 is able to bind both SMN (39) and importin ␤ (21) to facilitate nuclear import of mature snRNP complexes.
Recent studies have demonstrated that the zinc finger protein ZPR1 represents a new component of SMN complexes (16) . ZPR1 is part of a cytoplasmic snRNP complex that contains SMN, Sm proteins, U snRNA, snurportin 1, and importin ␤ (39). The binding partner of ZPR1 in the SMN complex has not yet been identified, but it has been established that ZPR1 does not directly bind SMN (16) . ZPR1 colocalizes with SMN in the nucleus, where both proteins accumulate in gems and Cajal bodies. It is likely that the binding of ZPR1 to SMN complexes is significant because SMN mutations that are associated with SMA disease disrupt the association of ZPR1 with SMN complexes (16) . Furthermore, it is established that SMA patients express low levels of ZPR1 (20) .
The purpose of this study was to examine the role of ZPR1 in mouse development. The effect of ZPR1 deficiency was investigated by disruption of the Zpr1 gene by using homologous recombination and also by Zpr1 gene silencing using RNA interference. We report that ZPR1 deficiency caused reduced growth and increased apoptosis. The effects of ZPR1 (PBS-T) for 30 min at 25°C. Coverslips were labeled with primary antibodies: anti-ZPR1 (clone LG1) (16), anti-Sm (clone Y12, LabVision); anti-TMG (Ab-1; Oncogene Research Products), anti-splicing factor SC-35 (Sigma), or anti-␤-tubulin (clone TUJI; Covance) and detected with secondary antibodies coupled with fluorophores (Molecular Probes). Actin was labeled with phalloidin conjugated with Alexa 546 (Molecular Probes). Apoptosis assays were performed by detection of activated caspases using a caspase detection kit (Oncogene Research Products) by labeling with fluorescein isothiocyanate (FITC)-VAD-fmk for 1 h in culture at 37°C. Double labeling (ZPR1-SMN) was carried out as described previously (16) by sequential incubations (1 h) with anti-SMN (clone 2B1) (30) , with Alexa 546-conjugated anti-mouse immunoglobulin G (IgG) secondary antibody (Molecular Probes), and then with Alexa 488-conjugated anti-ZPR1 (clone LG1) at 25°C. Double labeling (ZPR1-p80 coilin) was carried out by sequential incubations (1 h) with rabbit anti-p80 coilin (no. R288) (1) and Alexa 546-conjugated antirabbit IgG secondary antibody and then with Alexa 488-conjugated LG1 (anti-ZPR1) at 25°C.
Triple labeling (ZPR1-SMN-BrdU) was carried out by sequential incubations (1 h) with anti-SMN (clone 2B1), Cy5-conjugated anti-mouse IgG secondary antibody (Jackson Immunoresearch), FITC-conjugated antibody to BrdU (BD Pharmingen), and Alexa 546-conjugated antibody to ZPR1 (clone LG1) at 25°C.
Processed coverslips were mounted on slides with mounting medium (Vectashield) containing 4Ј,6-diamino-2-phenylindole (DAPI). Fluorescence microscopy was performed using a Ziess inverted microscope (Axiovert M200) or a confocal laser scanning microscope (Leica TCS SP2) equipped with a 405-nm diode laser. Fluorescence images were quantitated using software obtained from Leica. Differential interference contrast images were obtained using the Ziess inverted microscope.
Transmission electron microscopy. Mouse embryos (E3.5) were cultured for 96 h in 35-mm dishes (Nunc), washed with 0.5 M sodium cacodylate-HCl buffer (pH 7.0), and fixed with 2 ml of 1.25% gluteraldehyde for 30 min at 30°C and overnight at 4°C with 2 ml of 2.5% glutaraldehyde in cacodylate buffer. The embryos were postfixed (1 h) in 1% (wt/vol) osmium tetraoxide in 0.1 M phosphate buffer (pH 7.2). The fixed embryos were then washed with buffer and dehydrated through a graded ethanol series and transferred through a series of 100% ethanol and epoxy resin mixtures (LX 112/Araldite 502 epoxy resin) starting with 2 parts ethanol and 1 part epoxy resin, followed by a mixture of 1 part ethanol and 2 parts epoxy resin, and finally three changes of full-strength epoxy resin and were polymerized overnight at 70°C. The epoxy blocks were cut and mounted on blank epoxy stubs with a drop of Super Glue, and ultrathin sections were cut on a Reichart-Jung ultramicrotome using a diamond knife. The sections were collected and mounted on copper support grids in serial order, contrasted with lead citrate and uranyl acetate, and examined on a Philips CM 10 transmission electron microscope at 80-kV accelerating voltage.
Scanning electron microscopy. Mouse embryos were fixed as described for transmission electron microscopy, dehydrated in graded alcohol (30, 50, 70 , and 95% ethanol for 20 min each and then 100% ethanol twice for 20 min), and then critical-point dried in liquid CO 2 . The dried embryo samples were mounted onto aluminum stubs with silver conductive paste and sputter coated with gold-palladium alloy (60:40). The specimens were examined using an ETEC autoscan scanning electron microscope at 20-kV accelerating voltage.
RESULTS
Targeted disruption of the murine Zpr1 gene. To define the physiological role of ZPR1, we examined the effect of disruption of the murine Zpr1 gene. A targeting vector was designed to replace exon 1 of the Zpr1 gene with a Neo r cassette (Fig.  1A) . This vector was electroporated into embryonic stem cells. Four correctly targeted cell clones were identified by Southern blot analysis (Fig. 1B) . Two clones were injected into C57BL/6J blastocysts to obtain chimeric mice that were crossed with C57BL/6J mice. Chimeric mice derived from both of these clones transmitted the disrupted Zpr1 allele through the germ line (Fig. 1C) .
Comparison of wild-type and heterozygous Zpr1 Ϫ/ϩ mice did not lead to the detection of obvious morphological differences. Breeding Zpr1 Ϫ/ϩ mice yielded wild-type and heterozygous mice at weaning, but no homozygous Zpr1 Ϫ/Ϫ mice were examined the growth and development of E3.5 blastocysts in vitro. All embryos appeared to be similar when visualized under differential interference contrast light microscopy at E3.5 (0 h; Fig. 2A ). The blastocysts were cultured and observed at 24-h intervals. Both wild-type ( Fig. 2A ) and heterozygous Zpr1 Ϫ/ϩ (data not shown) embryos showed normal growth, spreading of trophoblast giant cells, and growth of the inner cell mass surrounded by trophectoderm. In contrast, Zpr1 Ϫ/Ϫ embryos were delayed in growth and failed to form normal trophectoderm and expand the inner cell mass ( Fig. 2A) . Addition of leukemia inhibitory factor stimulated the growth of the inner cell mass in wild-type and heterozygous Zpr1 Ϫ/ϩ embryos but did not affect the proliferation of these cells in Zpr1 Ϫ/Ϫ embryos (data not shown). Culture for 120 to 144 h resulted in substantial growth of wild-type and heterozygous embryos, but very few viable cells derived from Zpr1 Ϫ/Ϫ embryos were detected (data not shown).
To further characterize the growth of embryos, we examined cultured embryos by scanning electron microscopy. Wild-type embryos contained a large inner cell mass surrounded by trophectoderm formed by trophoblast giant cells (Fig. 2B, top) . Mutant embryos were significantly smaller. The inner cell mass of the mutant embryos contained only a few cells that were surrounded by a thin layer of irregular trophectoderm (Fig. 2B , top). Furthermore, higher magnification of these embryos showed marked differences in the apical surface of embryonic cells between wild-type and mutant embryos (Fig. 2B, bottom) . The surface of the cells that form the trophectoderm and inner cell mass of wild-type embryos contained a high density of specialized projections (microvilli) that increase cell surface area and are involved in transport-secretion, enzymatic activity, and signal transduction. In contrast, cells of mutant embryos showed a smooth surface and were devoid of microvilli (Fig. 2B ). These data demonstrate that ZPR1 deficiency caused defects in the apical surface of embryonic cells, including the loss of microvilli.
ZPR1 deficiency causes increased apoptosis. To determine the cause of the developmental defect observed in Zpr1 Ϫ/Ϫ embryos, we performed biochemical analysis of mouse embryos cultured in vitro. The impaired growth of Zpr1 Ϫ/Ϫ embryos ( Fig. 2A and B) suggested that ZPR1 deficiency might cause increased cell death. To test this hypothesis, we examined the activation of apoptotic caspases in cultured blastocysts by incubation with FITC-VAD-fmk. Confocal laser-scanning microscopy detected very little activated caspase in wild-type embryos (Fig. 2C) . In contrast, a marked increase in the amount of activated caspase was detected in Zpr1 Ϫ/Ϫ embryos. This observation suggests that ZPR1-deficient cells may exhibit increased apoptosis. Indeed, ultrastructural analysis by transmission electron microscopy demonstrated the presence of engulfed apoptotic bodies within the cytoplasm of the trophoblast giant cells of Zpr1 Ϫ/Ϫ embryos but not wild-type embryos (Fig.  2D) . Analysis of the inner cell mass of Zpr1 Ϫ/Ϫ embryos demonstrated the presence of cells with an early apoptotic morphology (chromatin condensation and nuclear folding; Fig.  2D ) and also cells undergoing late-stage apoptosis (data not shown). In contrast, no apoptosis within the inner cell mass of wild-type embryos was detected (Fig. 2D) . Together, these data indicate that increased apoptosis contributes to the poor development of Zpr1 Ϫ/Ϫ embryos. ZPR1 is required for proliferation. In addition to increased apoptosis (Fig. 2) , the poor development of Zpr1 Ϫ/Ϫ embryos may result from reduced cell proliferation. We therefore investigated DNA synthesis in wild-type and Zpr1 Ϫ/Ϫ embryos by examining the incorporation of BrdU into DNA during the S phase of the cell cycle (Fig. 3A) . Immunofluorescence analysis demonstrated that trophoblast giant cells did not incorporate BrdU in this assay. In contrast, marked incorporation of BrdU by the inner cell mass of wild-type embryos was observed. However, experiments using Zpr1 Ϫ/Ϫ embryos indicated that BrdU incorporation was restricted to only a few cells in the inner cell mass (Fig. 3A) . Together, these data demonstrated that Zpr1 Ϫ/Ϫ embryos exhibit a severe defect in proliferation. It is likely that this reduced proliferation (Fig. 3A) together with increased apoptosis (Fig. 2C and D) accounts, in part, for the death of Zpr1 Ϫ/Ϫ embryos. The absence of BrdU incorporation into the trophoblast giant cells in this assay most probably reflects the observation that these cells undergo several rounds of endoreduplication during early development prior to cell cycle arrest. To examine whether this early endoreduplication of trophoblast giant cells might be affected by ZPR1 deficiency, we quantitated the nuclear DNA by measurement of DAPI fluorescence (Fig. 3A) . The nuclear DNA content of ZPR1-deficient trophoblast giant cells was 52% Ϯ 11% (mean Ϯ standard deviation SD; n ϭ 10) of the nuclear DNA of wild-type trophoblast giant cells (Fig.  3A) . The cross-sectional area of the nucleus of ZPR1-deficient trophoblast giant cells was also smaller than that of wild-type cells (63% Ϯ 4%; n ϭ 10).
Together, these data indicate that ZPR1 deficiency causes reduced proliferation of the inner cell mass and reduced endoreduplication of the trophoblast giant cells.
ZPR1 deficiency causes defects in Cajal bodies. It has been established in previous studies that nuclear ZPR1 localizes to gems and Cajal bodies (16) . Cajal bodies were observed by transmission electron microscopy in both trophoblast giant cells and the inner cell mass of wild-type embryos (Fig. 2D) . In contrast, electron microscopy examination of serial sections of cells derived from Zpr1 Ϫ/Ϫ embryos failed to detect Cajal bodies (Fig. 2D) . These data suggest that ZPR1 deficiency causes major defects in the electron-dense structure of Cajal bodies. To test this hypothesis, we examined the subnuclear distribution of p80 coilin, a cytological marker for Cajal bodies (1). In wild-type embryos, a small amount of coilin was diffusely distributed within the nucleoplasm and the majority of coilin was found to accumulate in Cajal bodies (Fig. 3B) . In marked contrast, coilin was diffusely localized to the nucleoplasm in Zpr1 Ϫ/Ϫ embryos (Fig. 3B) . Interestingly, the total immunofluorescent staining of coilin in Zpr1 Ϫ/Ϫ cells was markedly increased compared to that in wild-type cells (Fig. 3B) . This The ZPR1-associated protein SMN is also a marker for gems and Cajal bodies (16, 30) . We therefore examined the localization of SMN in wild-type and Zpr1 Ϫ/Ϫ embryos. Immunofluorescence analysis of wild-type embryos demonstrated the presence of punctate intranuclear staining that colocalized with ZPR1 (Fig. 3C) . In contrast, punctate intranuclear localization of SMN was not observed in Zpr1 Ϫ/Ϫ embryos (Fig.  3C) .
Together, these data indicate that ZPR1 deficiency causes mislocalization of proteins (e.g., coilin and SMN) that normally accumulate in Cajal bodies and gems. This conclusion is consistent with the observation that electron microscopy detected Cajal bodies in wild-type embryos but not in Zpr1 Ϫ/Ϫ embryos (Fig. 2D) . The loss of Cajal bodies in Zpr1 Ϫ/Ϫ embryos is likely to be biologically significant because these subnuclear bodies have been implicated in multiple aspects of RNA biogenesis (14, 40) . Interestingly, it has been previously established that the association of coilin with Cajal bodies depends on active transcription since treatment of cells with actinomycin D causes relocalization of coilin from Cajal bodies to the nucleolar periphery (5, 47) .
ZPR1 is required for the normal subcellular distribution of spliceosomal snRNPs. It has been established in previous studies that SMN plays an important role in the assembly of the Sm-core domain of snRNPs in the cytoplasm (35, 43, 53) . In addition, cytoplasmic SMN can form a preimport snRNP complex with snurportin 1, importin ␤, and ZPR1 (39) . ZPR1 deficiency may therefore cause changes in the subcellular localization of snRNPs. To test this hypothesis, we examined wild-type and Zpr1 Ϫ/Ϫ embryos by immunofluorescence microscopy by staining with antibodies to Sm proteins (Fig. 4A) and to the TMG 5Ј-cap of U snRNA (Fig. 4B) . No marked differences between the distribution of Sm proteins and the TMG 5Ј-cap were observed, indicating that these epitopes primarily identify similar groups of snRNP complexes.
Immunofluorescence analysis demonstrated that ZPR1 deficiency caused major changes in the subcellular distribution of snRNPs (detected as Sm proteins or TMG 5Ј-cap). In wildtype embryos, snRNPs accumulated in the nucleus and were reproducibly detected in the cytoplasm. The location of snRNPs in both the nuclear and cytoplasmic compartments of wild-type cells is consistent with the established role of nuclear export and nuclear reimport during snRNP biogenesis (50) . In marked contrast, snRNPs were detected only at very low levels in the cytoplasm of ZPR1-deficient embryos (Fig. 4) . In addition, ZPR1 deficiency caused a marked change in the subnuclear localization of snRNPs because snRNPs were partially excluded from the nucleolus in wild-type embryos but accumulated within the nucleolus of Zpr1 Ϫ/Ϫ embryos (Fig. 4) . Interestingly, the effect of ZPR1 deficiency in causing localization of snRNPs within the nucleolus (Fig. 4) is similar to the effect of treatment of cells with the protein phosphatase inhibitor okadaic acid (32, 47) .
To further characterize the effect of ZPR1 deficiency on the subcellular localization of Sm proteins and snRNPs, we performed quantitative analysis of images obtained by confocal immunofluorescence miscoscopy. The cytoplasmic and nuclear Sm protein staining in wild-type cells was 33% Ϯ 2% and 67% Ϯ 2% (n ϭ 10), respectively. In contrast, ZPR1-deficient cells showed decreased cytoplasmic ZPR1 staining (2% Ϯ 1%) and increased nuclear staining (98% Ϯ 1%; n ϭ 10). Quantitation of the staining of snRNPs indicated cytoplasmic and nuclear staining of 37% Ϯ 3% and 63% Ϯ 3% (n ϭ 10), respectively. ZPR1 deficiency caused decreased staining of snRNPs in the cytoplasm (11% Ϯ 2%) and increased staining in the nucleus (89% Ϯ 2%; n ϭ 10). These quantitative data confirm the conclusion that ZPR1 deficiency caused decreased cytoplasmic accumulation and increased nuclear accumulation of both Sm proteins and snRNPs. Together, these data indicate that ZPR1 deficiency causes major defects in the subcellular localization of snRNPs. This observation suggested that ZPR1 deficiency may alter the normal function of spliceosomal snRNPs. Previous studies have demonstrated that the SC35 splicing factor can be detected in "nuclear speckles" and that these speckles aggregate when pre-mRNA splicing is disrupted (41) . We therefore examined the subnuclear localization of the SC35 splicing factor. Immunofluorescence analysis demonstrated aggregation of the SC35 "nuclear speckles" in ZPR1-deficient embryos (data not shown). Together, these data indicate that ZPR1 deficiency influences snRNP complexes, the major target of SMN activity.
RNA interference-mediated suppression of Zpr1 gene expression causes mislocalization of SMN and snRNPs. SMA is caused by the degeneration of ␣-motor neurons of the spinal cord. Motor neurons therefore represent a cell type that is relevant to SMA disease. Since Zpr1 Ϫ/Ϫ mice die during early embryonic development, we were not able to study Zpr1 Ϫ/Ϫ motor neurons. Consequently, we used an alternative approach, Zpr1 gene silencing by siRNA, to examine the effect of ZPR1 deficiency. These studies were performed using the NSC-34 mouse cell line, which can be induced to differentiate into cells that have motor neuron-like properties. Control studies demonstrated that these cells express both ZPR1 and SMN (Fig. 5A) . Immunofluorescence analysis demonstrated extensive colocalization of ZPR1 and SMN in the soma and growth cones. The amount of nuclear accumulation of SMN and ZPR1 in these cells was small, but SMN and ZPR1 were found to colocalize in gems and Cajal bodies (Fig. 5A and B) . Zpr1 siRNA, but not scambled siRNA, caused decreased expression of ZPR1 detected by immunoblot analysis (see Fig. S1 in the supplemental material). Similarly, immunofluorescence analysis demonstrated that Zpr1 siRNA, but not scrambled siRNA (Control), caused decreased expression of ZPR1 (Fig. 5B) . Interestingly, both ZPR1 and SMN were detected in gems and Cajal bodies in control cells, but this localization was not detected following Zpr1 gene silencing (Fig. 5B) . Similarly, coilin was localized to Cajal bodies in differentiated NSC-34 cells but was found to be diffusely distributed in the nucleoplasm following Zpr1 gene silencing (data not shown). These data confirm that ZPR1 is essential for the localization of SMN to gems and Cajal bodies.
To investigate whether ZPR1 influences snRNPs in NSC-34 cells, we examined the localization of snRNPs by immunofluorescence analysis using an antibody to the TMG 5Ј-cap of U snRNA that is assembled into snRNP complexes (Fig. 5C ). Differentiated NSC-34 cells transfected with scrambled siRNA (Control) demonstrated the presence of snRNP in both the cytoplasm and the nucleus. In contrast, no cytoplasmic snRNPs were detected in cells following Zpr1 gene silencing. Furthermore, snRNPs were excluded from the nucleolus of control motor neurons but were present in the nucleolus of ZPR1-depleted cells.
Together, these data demonstrate that ZPR1 deficiency causes defects in the localization of both SMN and spliceosomal snRNPs in early embryos (Fig. 3 and 4) and cultured NSC-34 cells (Fig. 5) .
ZPR1 deficiency causes axonal defects. Axonal defects in motor neurons as a result of SMN deficiency have been described, and it is likely that such defects contribute to the pathogenesis of SMA (34, 44) . We therefore examined whether ZPR1 deficiency might cause axonal defects in NSC-34 cells. Morphology was assessed by immunofluorescence analysis using an antibody to tubulin and phalloidin to stain actin (Fig. 6 ). Neurons transfected with scrambled siRNA (Control) demonstrated the presence of tubulin in axons and actin in both the soma and growth cones. Zpr1 gene silencing caused retraction of growth cones and disruption of the structural integrity of axonal microtubules. Control axons were long and straight, whereas the axons of ZPR1-deficient neurons were kinked and short. These data indicate that ZPR1 is important for the maintenance of motor neuron axons and growth cones. ZPR1 is essential for cell survival. The apoptotic degeneration of motor neurons in SMA patients causes progressive muscle weakness. Since these patients express low levels of ZPR1 (20), we considered the possibility that ZPR1 deficiency might contribute to motor neuron death. To test this hypothesis, we investigated the effect of Zpr1 gene silencing on caspase activation in differentiated NSC-34 cells. Activated caspase was detected by immunofluorescence analysis after incubation of the motor neurons with FITC-VAD-fmk. Cells transfected with scrambled siRNA (Control) did not exhibit caspase activation (Fig. 7A) . In contrast, caspase activation was observed in cultures of neurons transfected with Zpr1 siRNA. The most prominent staining of activated caspase appeared to correspond to apoptotic bodies derived from dead cells that were adherent to viable cells (Fig. 7A) .
The observation that ZPR1 deficiency is associated with caspase activation suggests that the loss of ZPR1 might cause apoptosis. To test this hypothesis, we examined the effect of transfecting cultures of NSC-34 cells with scrambled siRNA or Zpr1 siRNA. The cells were cultured for 72 h, and the number of surviving neurons was examined by staining nuclear DNA with DAPI (Fig. 7B) . Zpr1 gene silencing caused marked decreases in both the level of ZPR1 expression and the number of surviving neurons. The decreased neuronal survival was prevented by incubation with the caspase inhibitor zVAD-fmk (Fig. 7B) . Together, these data demonstrate that ZPR1 is critical for sustaining cell survival.
DISCUSSION
The results of this study establish that Zpr1 is an essential gene in mice (Table 1 ) and that ZPR1 is required for the maintenance of motor neurons ( Fig. 6 and 7) . The ZPR1 protein interacts with SMN and is a component of cytoplasmic snRNP complexes (16, 39) . The observation that ZPR1 deficiency causes defects in the subcellular localization of snRNPs and SMN (Fig. 3 to 5) indicates that the interaction between ZPR1 and SMN is biologically significant. Interestingly, SMN mutations that are associated with the inherited disease SMA disrupt the interaction of ZPR1 with SMN (16) . Furthermore, human patients with SMA express low levels of ZPR1 (20) . In mice, ZPR1 deficiency prevents the localization of SMN to gems and Cajal bodies ( Fig. 3 and 5) ; this may be significant for SMA because it is established that the severity of SMA negatively correlates with the number of SMN-positive gems and Cajal bodies (7, 29) . Together, these data indicate that ZPR1 may contribute to SMN-associated disease.
ZPR1 and SMN prevent apoptosis. SMN functions as a component of a protein complex (17) that includes the zinc finger protein ZPR1 (16, 39) . SMN mutations that cause SMA disrupt the interaction of SMN with several components of this protein complex, including ZPR1 (16) . The correlation between the interaction of ZPR1 with SMN and motor neuron degeneration in SMA suggests that ZPR1 and SMN may represent components of a common functional pathway.
It is established that loss of function, or mutation, of SMN can induce caspase-mediated apoptosis (22, 26, 45, 49) . Similarly, mutation or silencing of the murine Zpr1 gene causes casapse activation and apoptosis ( Fig. 2 and 7) . The mechanism of apoptosis caused by Smn and Zpr1 mutations may be related, since it is known that SMN is essential for splicesomal snRNP assembly and maturation (35, 43, 53) and that ZPR1 deficiency causes defects in the subcellular localization of both SMN and snRNPs (Fig. 4 and 5) . Interestingly, these effects of ZPR1 deficiency on the subcellular distribution of snRNPs and apoptosis resemble the effects of decreased expression of the SMN-interacting protein Gemin2 (23) . Together, these data indicate that both ZPR1 and the SMN protein complex can function to sustain cell survival.
Nucleocytoplasmic trafficking and function of ZPR1. ZPR1 redistributes between the cytoplasm and the nucleus (12, 13, 15) . Genetic analysis indicates that the nuclear export of ZPR1 requires the peptidylprolyl isomerase activity of cyclophilin A (2), while biochemical studies suggest that snurportin 1 may contribute to the nuclear import of ZPR1 (39) . This nucleocytoplasmic trafficking of ZPR1 resembles the trafficking of SMN (16) , although it should be noted that the nuclear import of ZPR1 and SMN appear to be mediated by independent mechanisms (38) and it is unclear whether the mechanisms of ZPR1 and SMN export from the nucleus are related. Nevertheless, SMN and ZPR1 are both detected in the cytoplasm and the nucleus. The cytoplasmic function of ZPR1 may be to collaborate with SMN in the assembly and maturation of snRNPs to form preimport complexes with snurportin 1 (39). The effect of ZPR1 deficiency to disrupt the cytoplasmic localization of snRNP complexes is consistent with this hypothesis (Fig. 4 and 5) .
In the nucleus, SMN and ZPR1 are found in the nucleoplasm, but these proteins also accumulate in gems and Cajal bodies (16, 30) . These subnuclear bodies have been implicated in several aspects of RNA biogenesis (14, 33, 40) . For example, recent studies have established that the guide RNA molecules that are required for site-specific modification of snRNAs are localized to Cajal bodies (27) and it has been demonstrated that the synthesis of 2-O-methylated nucleotides and pseudouridine in snRNAs occurs following nuclear import of snRNPs within Cajal bodies (25) . Interestingly, Cajal bodies were not detected in Zpr1 Ϫ/Ϫ embryos ( Fig. 2D and 3B ). Thus, ZPR1 may play an essential role in the maintenance of nuclear gems and Cajal bodies. Since these subnuclear bodies are dynamic structures that can exchange their protein components with the nucleoplasm (8) , there are several possible mechanisms that could account for the requirement of ZPR1 to maintain these structures. Nevertheless, it appears that in addition to a cytoplasmic function that may contribute to the assembly of snRNPs and formation of preimport snRNP com- (1) . The coilin NH 2 -terminal region is able to self-associate (18) , and the COOH terminus is able to recruit SMN by binding to symmetrical dimethylarginine residues located within an Arg-Gly-rich domain (3, 19) . A major difference between cells that display gems and those that do not is that the COOH-terminal region of coilin is hypomethylated in cells containing gems and Cajal bodies and is fully methylated in cells containing only Cajal bodies (19) . Interestingly, the COOH-terminal region of coilin can regulate the number of Cajal bodies (46) , and deletion of this region prevents the recruitment of both SMN and snRNP complexes to Cajal bodies (48) . In Zpr1 Ϫ/Ϫ embryos, Cajal bodies were not detected by electron microscopy (Fig. 2D ) and the nuclear distribution of coilin was profoundly altered (Fig. 3B) . Consistent with the established role of coilin to recruit SMN, no accumulation of SMN in Cajal bodies was observed in Zpr1 Ϫ/Ϫ embryos. It is possible that ZPR1 deficiency results in the formation of residual gems or Cajal bodies that lack coilin and SMN. Nevertheless, these data demonstrate that ZPR1 is essential for the normal morphology of gems and Cajal bodies.
Conclusions. Our studies of Zpr1 gene silencing and Zpr1 gene disruption demonstrate that ZPR1 is an essential protein. ZPR1 deficiency causes defects in both the cytoplasmic and nuclear populations of spliceosomal snRNPs. Specifically, cytoplasmic snRNPs are not detected in Zpr1 Ϫ/Ϫ embryos. Furthermore, ZPR1 deficiency markedly disrupts the subnuclear structures (gems and Cajal bodies) where final maturation of snRNP complexes is observed. These data are consistent with a collaborative role of ZPR1 in the function of SMN to mediate snRNP assembly/maturation and cell survival. The low level of ZPR1 expression in patients with spinal muscular atrophy may therefore contribute to disease progression.
